Spanish soccer giants Atletico Madrid made 'considerable progress' with various brands over a new naming rights partnership for the club’s stadium, with financial services company Allianz among the brands linked to a deal.
However, none has come to fruition so far.
Allianz already owns the naming rights to the stadiums of German champions Bayern Munich and Italian heavyweights Juventus, while snapping up the naming rights for the redeveloped sports stadium at Sydney’s Moore Park in March.
Atletico’s previous stadium naming rights deal with Chinese conglomerate the Wanda Group, reportedly worth US$52.6 million, expired at the end of the season. The firm had been the venue’s naming rights partner since it opened in 2017. The deal equated to US$10.5 million per season.
Atletico has renewed their sleeve sponsorship agreement with South Korean automotive manufacturer Hyundai for the 2022/23 campaign. The pair have been partners since 2018.


Trump's Transgender Sports Ban Faces Enforcement Challenges
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
WTO Digital Trade Talks Stall as E-Commerce Tariff Deadline Looms
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
Los Angeles Mayor Says White House Must Reassure Fans Ahead of FIFA World Cup
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Oil Prices Surge Past $100 as U.S.-Iran Peace Hopes Collapse
‘The geezer game’ – a nearly 50-year-old pickup basketball game – reveals its secrets to longevity
Champions League final 2025: a battle for glory against a backdrop of money and fashion
Trump Set to Announce Washington D.C. as Host of 2027 NFL Draft
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



